Barclays Maintains Underweight on FMC, Lowers Price Target to $4
Barclays analyst Benjamin Theurer maintains FMC (NYSE:FMC) with a Underweight and lowers the price target from $9 to $4.
Stocks · News reference
FMC Warns Of Staggering Losses, Slashes Revenue Outlook
FMC stock plunged over 36% after slashing Q3 revenue guidance and announcing sweeping pricing overhauls to combat generic competition.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
BMO Capital Maintains Market Perform on FMC, Lowers Price Target to $7.5
BMO Capital analyst Joel Jackson maintains FMC (NYSE:FMC) with a Market Perform and lowers the price target from $11 to $7.5.
This Workday Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
Analysts downgraded Varonis, Eastman Chemical, Workday and FMC; price targets fell for Eastman, Varonis and FMC.
Jefferies Downgrades FMC to Hold, Lowers Price Target to $5